Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study

The Lancet Neurology

Volumn 7, Issue 9, 2008, Pages 787-795

  Meyer, Brett C ^a   Raman, Rema ^a   Hemmen, Thomas ^a   Obler, Richard ^a   Zivin, Justin A ^a   Rao, Ramesh ^b   Thomas, Ronald G ^a   Lyden, Patrick D ^a,c  

^a El Centro   (United States)

^b CA Info Telecom and Technology   (United States)

^c Department of Veteran's Affairs   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

AGED; ALCOHOL CONSUMPTION; ARTICLE; BARTHEL INDEX; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; INTERNET; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; STROKE; TELECONSULTATION; TELEMEDICINE; TRANSIENT ISCHEMIC ATTACK;

AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; EMERGENCY MEDICAL SERVICES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE; REFERRAL AND CONSULTATION; STROKE; TELEMEDICINE; TELEPHONE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VIDEOCONFERENCING;

EID: 48849098929     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(08)70171-6     Document Type: Article

References (36)

1. Reeves M.J., Arora S., Broderick J.P., et al. Acute stroke care in the USA: results from four pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 36 (2005) 1232-1240
2. Hacke W., Donnan G., Fieschi C., et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363 (2004) 768-774
3. The NINDS rt-PA stroke study group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
4. Katzan I.L., Furlan A.J., Lloyd L.E., et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the cleveland area experience. JAMA 283 (2000) 1151-1158
5. Sable C.A., Cummings S.D., Pearson G.D., et al. Impact of telemedicine on the practice of pediatric cardiology in community hospitals. Pediatrics 109 (2002) 1-7
6. Rogers F.B., Ricci M.R., Caputo M., et al. The use of telemedicine for real-time video consultation between trauma center and community hospital in a rural setting improves early trauma care: preliminary results. J Trauma 51 (2001) 1037-1041
7. Wong H.T., Poon W.S., Jacobs P., et al. The comparative impact of video consultation on emergency neurosurgical referrals. Neurosurgery 59 (2006) 607-661
8. Levine S.R.M. "Telestroke": the application of telemedicine for stroke. Stroke 30 (1999) 464-469
9. Wang S., Lee S.B., Pardue C., et al. Remote evaluation of acute ischemic stroke: reliability of national institutes of health stroke scale via telestroke. Stroke 34 (2003) 188e-191e
10. Meyer B.C., Lyden P.D., Al-Khoury L., et al. Prospective reliability of the STRokE DOC wireless/site independent telemedicine system. Neurology 64 (2005) 1058-1060
11. Shafqat S., Kvedar J.C., Guanci M.M., Chang Y., and Schwamm L.H. Role for telemedicine in acute stroke. Feasibility and reliability of remote administration of the NIH stroke scale. Stroke 30 (1999) 2141-2145
12. Handschu R., Littmann R., Reulbach U., et al. Telemedicine in emergency evaluation of acute stroke: interrater agreement in remote video examination with a novel multimedia system. Stroke 34 (2003) 2842-2846
13. Frey J.L., Jahnke H.K., Goslar P.W., Partovi S., and Flaster M.S. tPA by telephone: extending the benefits of a comprehensive stroke center. Neurology 64 (2005) 154-156
14. LaMonte M.P., Bahouth M.N., Hu P., et al. Telemedicine for acute stroke: triumphs and pitfalls. Stroke 34 (2003) 725-728
15. Schwab S., Vatankhah B., Kukla C., et al. Long-term outcome after thrombolysis in telemedical stroke care. Neurology 69 (2007) 898-903
16. Audebert H.J., Kukla C., Vatankhah B., et al. Comparison of tissue plasminogen activator administration management between telestroke network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany. Stroke 37 (2006) 1822-1827
17. Roine R., Ohinmaa A., and Hailey D. Assessing telemedicine: a systematic review of the literature. CMAJ 165 (2001) 765-771
18. Meyer B.C., Raman R., Rao R., et al. The stroke team remote evaluation using a digital observation camera (stroke doc) telemedicine clinical trial technique: video clip, drip and/ or ship. Int J Stroke 2 (2007) 281-287
19. Stiratelli R., Laird N., and Ware J.H. Random-effects models for serial observations with binary response. Biometrics 40 (1984) 961-971
20. Hess D.C., Wang S., Gross H., Nichols F.T., Hall C.E., and Adams R.J. Telestroke: extending stroke expertise into underserved areas. Lancet Neurol 5 (2006) 275-278
21. Schwamm L.H., Rosenthal E.S., Hirshberg A., et al. Virtual telestroke support for the emergency department evaluation of acute stroke. Acad Emerg Med 11 (2004) 1193-1197
22. Audebert H.J., Schenkel J., Heuschmann P.U., Bogdahn U., and Haberl R.L. Effects of the implementation of a telemedical stroke network: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria, Germany. Lancet Neurol 5 (2006) 742-748
23. Wiborg A., and Widder B. Teleneurology to improve stroke care in rural areas: the Telemedicine in Stroke in Swabia (TESS) Project. Stroke 34 (2003) 2951-2956
24. Alberts M.J., Latchaw R.E., Selman W.R., et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 36 (2005) 1597-1616
25. California Acute Stroke Pilot Registry (CASPR) Investigators. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology 64 (2005) 654-659
26. Brown D.L., Barsan W.G., Lisabeth L.D., Gallery M.E., and Morgenstern L.B. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke. Ann Emerg Med 46 (2005) 56-60
27. Mecozzi A.C., Brown D.L., Lisabeth L.D., et al. Determining intravenous rt-PA eligibility in the emergency department. Neurocrit Care 7 (2007) 103-108
28. American College of Emergency Physicians. Policy statement: use of intravenous tPA for the management of acute stroke in the emergency department. Ann Emerg Med 40 (2002) 551
29. Katzan I., Hammer M., and Furlan A. Quality improvement and tissue-type plasminogen activator for acute ischemic stroke. a Cleveland update. Stroke 34 (2003) 799
30. Audebert H.J., Wimmer M.L., Hahn R., et al. Can telemedicine contribute to fulfill WHO Helsingborg declaration of specialized stroke care?. Cerebrovasc Dis 20 (2005) 362-369
31. Dreezen I. Telemedicine and informed consent. Med Law 23 (2004) 541-549
32. Adams Jr. H.P., del Zoppo G., Alberts M.J., et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 115 (2007) e478-e534
33. Saver J.L. Time is brain-quantified. Stroke 37 (2006) 263-266
34. Lyden P.D., Lu M., Levine S., Brott T.G., and Broderick J. A modified National Institutes of Health Stroke scale for use in stroke clinical trials. preliminary reliability and validity. Stroke 32 (2001) 1310-1317
35. Meyer B.C., Hemmen T.M., Jackson C., and Lyden P.D. Modified National Institutes of Health Stroke Scale for use in stroke clinical trials. Stroke 33 (2002) 1261-1266
36. Saver J.L. Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm. Stroke 38 (2007) 2279-2283